For chronic use of statins and renin inhibitors, inverse associations for studies with a low/moderate risk of bias due to confounding were observed for COVID-19-related death and COVID-19 severity, but there was an increased risk of both outcomes in studies with a high risk of bias due to confounding (ESM Figs. 62 and 63). This evidence concerns the gene REN and COVID-19.